Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 45 (RPL31P45)

Target
RPL31P45
Molecular classification
Other (pseudogene, not a protein-coding ribosomal protein), Not an enzyme, transporter, receptor, or ion channel
01

Overview

Ribosomal protein L31 pseudogene 45 (RPL31P45) is a **processed pseudogene** of the gene encoding ribosomal protein L31 (RPL31), which is a component of the 60S large ribosomal subunit and plays a role in protein synthesis in the cytoplasm[1][2][6]. In humans, many such pseudogenes exist for ribosomal protein genes, but **RPL31P45 does not encode a functional protein and has no described biological role, disease linkage, or relevance as a drug target**. The actual *ribosomal protein L31* is a structural component of the ribosome, with implications in inherited anemias when mutated, but these properties do not pertain to *RPL31P45*, which is non-coding[1][2][6]. \n\n**Important notes:**\n- RPL31P45 is not a therapeutic target; it is a non-functional pseudogene.\n- The canonical protein-coding gene is **Ribosomal protein L31 (RPL31)**[1][2][4], not RPL31P45.\n- The entry is technically *incorrect as a drug target* and is often included by mistake in non-curated gene lists[6]. \n\n**Summary for downstream structuring:** \n- The entry “ribosomal protein L31 pseudogene 45 (RPL31P45)” is a **processed pseudogene**, not a valid drug target, receptor, enzyme, or therapeutic entity. It should not be considered for further drug discovery or clinical development activities.

Other names
RPL31P45ribosomal protein L31 pseudogene 45
02

Mechanism of action

Not applicable

03

Biological functions

None for the pseudogene itself; pseudogenes generally do not encode functional protein. The parent gene (RPL31) is involved in *ribosome structure* and *protein synthesis*, but this does **not** apply to RPL31P45
04

Disease associations

None established for the pseudogene.

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 45 (RPL31P45).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 45 (RPL31P45).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call